ATE480533T1 - Variolinderivate und ihre verwendung als cytostatika - Google Patents
Variolinderivate und ihre verwendung als cytostatikaInfo
- Publication number
- ATE480533T1 ATE480533T1 AT07013582T AT07013582T ATE480533T1 AT E480533 T1 ATE480533 T1 AT E480533T1 AT 07013582 T AT07013582 T AT 07013582T AT 07013582 T AT07013582 T AT 07013582T AT E480533 T1 ATE480533 T1 AT E480533T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- derivatives
- unsubstituted
- varioline
- cytostatics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Carbon And Carbon Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0116966.3A GB0116966D0 (en) | 2001-07-11 | 2001-07-11 | Anittumoral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE480533T1 true ATE480533T1 (de) | 2010-09-15 |
Family
ID=9918335
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07013582T ATE480533T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
AT02745614T ATE396987T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02745614T ATE396987T1 (de) | 2001-07-11 | 2002-07-11 | Variolinderivate und ihre verwendung als cytostatika |
Country Status (20)
Country | Link |
---|---|
US (2) | US7495000B2 (de) |
EP (2) | EP1867645B1 (de) |
JP (1) | JP4369225B2 (de) |
KR (1) | KR100929616B1 (de) |
CN (1) | CN1553906B (de) |
AT (2) | ATE480533T1 (de) |
AU (1) | AU2002317329B2 (de) |
CA (1) | CA2453418C (de) |
DE (2) | DE60226869D1 (de) |
ES (2) | ES2307768T3 (de) |
GB (1) | GB0116966D0 (de) |
HK (1) | HK1060354A1 (de) |
HU (1) | HUP0402658A2 (de) |
IL (2) | IL159792A0 (de) |
MX (1) | MXPA04000355A (de) |
NO (1) | NO328848B1 (de) |
NZ (1) | NZ530556A (de) |
PL (1) | PL366894A1 (de) |
RU (1) | RU2302419C2 (de) |
WO (1) | WO2003006457A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1299388T1 (sl) | 2000-07-11 | 2009-12-31 | Pharma Mar Sa | Derivati variolina kot proti rakavi agensi |
GB0019117D0 (en) | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
EP2706059A1 (de) * | 2008-06-11 | 2014-03-12 | Genentech, Inc. | Diazacarbazole und Verwendungsverfahren |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1299388T1 (sl) | 2000-07-11 | 2009-12-31 | Pharma Mar Sa | Derivati variolina kot proti rakavi agensi |
GB0019117D0 (en) * | 2000-08-03 | 2000-09-27 | Univ Barcelona | Derivatives of variolin B |
GB0116966D0 (en) * | 2001-07-11 | 2001-09-05 | Pharma Mar Sa | Anittumoral compounds |
-
2001
- 2001-07-11 GB GBGB0116966.3A patent/GB0116966D0/en not_active Ceased
-
2002
- 2002-07-11 DE DE60226869T patent/DE60226869D1/de not_active Expired - Lifetime
- 2002-07-11 CA CA2453418A patent/CA2453418C/en not_active Expired - Fee Related
- 2002-07-11 HU HU0402658A patent/HUP0402658A2/hu unknown
- 2002-07-11 EP EP07013582A patent/EP1867645B1/de not_active Expired - Lifetime
- 2002-07-11 DE DE60237652T patent/DE60237652D1/de not_active Expired - Lifetime
- 2002-07-11 MX MXPA04000355A patent/MXPA04000355A/es active IP Right Grant
- 2002-07-11 RU RU2004103857/04A patent/RU2302419C2/ru not_active IP Right Cessation
- 2002-07-11 AT AT07013582T patent/ATE480533T1/de not_active IP Right Cessation
- 2002-07-11 AU AU2002317329A patent/AU2002317329B2/en not_active Ceased
- 2002-07-11 EP EP02745614A patent/EP1404668B1/de not_active Expired - Lifetime
- 2002-07-11 ES ES02745614T patent/ES2307768T3/es not_active Expired - Lifetime
- 2002-07-11 NZ NZ530556A patent/NZ530556A/en not_active IP Right Cessation
- 2002-07-11 ES ES07013582T patent/ES2354991T3/es not_active Expired - Lifetime
- 2002-07-11 PL PL02366894A patent/PL366894A1/xx not_active Application Discontinuation
- 2002-07-11 US US10/483,525 patent/US7495000B2/en not_active Expired - Fee Related
- 2002-07-11 IL IL15979202A patent/IL159792A0/xx unknown
- 2002-07-11 WO PCT/GB2002/003197 patent/WO2003006457A1/en active IP Right Grant
- 2002-07-11 AT AT02745614T patent/ATE396987T1/de not_active IP Right Cessation
- 2002-07-11 JP JP2003512229A patent/JP4369225B2/ja not_active Expired - Fee Related
- 2002-07-11 KR KR1020047000500A patent/KR100929616B1/ko not_active IP Right Cessation
- 2002-07-11 CN CN028175298A patent/CN1553906B/zh not_active Expired - Fee Related
-
2004
- 2004-01-11 IL IL159792A patent/IL159792A/en not_active IP Right Cessation
- 2004-01-12 NO NO20040113A patent/NO328848B1/no not_active IP Right Cessation
- 2004-05-07 HK HK04103219A patent/HK1060354A1/xx not_active IP Right Cessation
-
2009
- 2009-01-07 US US12/349,813 patent/US7772241B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69418704D1 (de) | Anthranilsäure derivate | |
ATE141589T1 (de) | Alkoxyiminoacetamid-derivate und ihre verwendung als pilztötendes mittel | |
DE69927039D1 (de) | Synthetische analoge des ecteinascidin-743 | |
MXPA04001240A (es) | Analogos antitumorales. | |
ATE88714T1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
MXPA02006329A (es) | 8-arilquinolinas sustituidas que son inhibidores de fosfodiesterasa-4. | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
DE3776044D1 (de) | Pyridazinon-derivate. | |
ATE396987T1 (de) | Variolinderivate und ihre verwendung als cytostatika | |
DE69624459D1 (de) | Kondensierte indan-derivate und ihre salze | |
DE60116855D1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität | |
DE59908820D1 (de) | Azadioxacycloalkene derivate, verfahren zu deren herstellung sowie deren verwendung als fungizide und schädlingsbekämpfungsmittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |